The CDC's advisory committee is hoping a continued pause will allow for better data about the potential risks of Janssen's covid vaccine. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
